Spencer Trask & Co.
| Industry | Financial services |
|---|---|
| Headquarters | Greenwich, CT, United States |
|
Key people
|
Kevin Kimberlin (Chairman) William Clifford (CEO) |
| Services | Build advanced technology companies |
| Website | spencertraskco |
Spencer Trask & Co. is a privately held advanced technology development company. The firm works with entrepreneurs, CEOs, corporate partners, venture firms and high net worth individuals to start and grow high impact ventures.
Members and affiliates of Spencer Trask & Co. are founders of, advisors to, and investors in private and public companies through direct investments, a brokerage affiliate and numerous limited liability companies.
Spencer Trask & Co., has been instrumental in the formative stage of companies that pioneered many technological and scientific advancements, including: genomics with Myriad Genetics,healthcare reform with Health Dialog, patent development with Intellectual Ventures, the Internet with Ciena,cloud computing infrastructure with Aperture, and open innovation with Innocentive and inno360 (in partnership with P&G, and the Air Force Research Labs), through Spencer Trask & Co. affiliate, Spencer Trask Collaborative Innovations (STCI). STCI facilitates collaborative innovation on a massive scale. Collaboration, which is the foundation of STCI’s focus, has been described as transforming the world from "mass production to mass collaboration" by top thinkers such as visionary and STCI board member Don Tapscott.
Several Spencer Trask-backed technologies and companies have been acquired recently, including OpenTable ($2.6 billion), Prolor (stock swap worth $1.2 billion), El Super (2013 revenues topped $1.1 billion) and Prospect Medical ($363 million).
The firm is the legacy of Mr. Spencer A. Trask who financed Thomas Edison and was founding trustee of the predecessor to General Electric, the president of the first electricity firm, Consolidated Edison, and chairman of the New York Times.
...
Wikipedia